Team
Amorphex Therapeutics has brought together a product development and management team with extensive experience in ophthalmic products. This team has worked together in the past and has developed and successfully launched numerous ophthalmic products for Bausch and Lomb.
Robert Thompson
President & CEO
Bob has extensive marketing and operational executive experience in medical product markets. In addition to considerable experience in ophthalmic markets, he has been involved in start-up projects ranging from a device for GI closures to a fertility testing product. He was formerly a corporate officer of Bausch & Lomb and president of Polymer Technology Corporation. He joined Polymer Technology in its early, venture capital financed stage prior to acquisition by Bausch & Lomb. There he held various sales and marketing executive positions with the company during its sustained growth to become the world’s leading provider of gas permeable contact lens products. Independent of B&L he has also acted as the intermediary in the sale of several ophthalmic product lines. Bob is a graduate of Boston University’s School of Management and of Harvard Business School PMD.
Charles Leahy, OD, MS
Vice President, Clinical Affairs
Dr. Leahy brings to Amorphex his demonstrated clinical expertise in the development of ophthalmic products. He has been an investigator in more than 60 clinical studies of developmental ophthalmic pharmaceuticals and devices. And he has consulted and co-managed new technology/product programs with the product development teams at Bausch & Lomb. Dr. Leahy is also a co-founder of Vista Scientific. He received his Doctor of Optometry degree from New England College of Optometry and a Masters in Physiological Optics from University of California at Berkeley. As an Assistant Professor in Ophthalmology, Dr. Leahy provides patient care and resident training at the Massachusetts Eye and Ear Infirmary of Harvard Medical School.
Kathryn Crawford, Ph.D.
Vice President, Regulatory and Quality
Dr. Crawford has over 25 years of experience in early stage biotech and pharmaceutical development, particularly in eye diseases, holding senior positions in both academia and industry. Dr. Crawford has managed numerous preclinical development programs, with expertise in animal studies and disease models, with specific interest in ophthalmology. As principal investigator, she has been awarded multiple NIH Small Business Innovation Research grants, and has been selected several times to serve on NIH SBIR review committees as an expert panelist reviewer. Dr. Crawford has authored over 30 publications in high impact peer-reviewed journals, and has been invited to present her research at national and international conferences. Dr. Crawford holds a Bachelor's Degree in Zoology and a Ph.D. in Pharmacology, both from the University of Wisconsin, Madison
Edward Ellis, Ph.D.
Vice President, Technology
Dr. Ellis brings to Amorphex over 25 years of ophthalmic product development experience and is an inventor of over 30 US issued patents. He is responsible for creating over a dozen ophthalmic products with combined revenues in the billions of dollars. Dr. Ellis worked as Senior Vice President of Science and Technology for Bausch & Lomb. He was also a cofounder of Polymer Technology Corporation that was later acquired by Bausch & Lomb. Dr. Ellis founded Vista Scientific in 1997 to develop novel ophthalmic products. He completed his Bachelors, Masters and Ph.D. in Polymer Science at the University of Massachusetts.
Jeanne Ellis, MS
Manager, Chemical Research
Ms. Ellis brings to Amorphex over 25 years of experience in ophthalmic product development. She is an inventor of over 10 US issued patents and has contributed to the development of over a dozen contact lens and solution products. Ms Ellis has worked as a senior scientist for Bausch & Lomb. She is also a cofounder Vista Scientific. Ms. Ellis received her Bachelors Degree in Chemical Engineering from National Taiwan University and double Masters Degrees in Polymer Science and Plastics Engineering from the University of Massachusetts.
Amorphex Management Team